Founded in 1981 in Danvers, Massachusetts, ABIOMED develops heart-recovery technology, best known for its Impella catheter-based heart pumps that provide temporary mechanical circulatory support. The company pairs its devices with clinical education and on-site, on-call, and online support for healthcare teams. ABIOMED became part of Johnson & Johnson MedTech through an acquisition, with more than 400,000 patients treated with Impella pumps worldwide.
Johnson & Johnson MedTechJohnson & Johnson MedTech develops medical devices and technologies for surgery, orthopaedics, cardiovascular care and other areas of medical intervention. Its portfolio brings together businesses including Biosense Webster, which focuses on diagnosing and treating cardiac arrhythmias, DePuy Synthes, Ethicon and Mentor. The company traces its healthcare innovation back more than a century and works across biology and technology to support smarter, less invasive and more personalized care.339112WEST CHESTER, PA
ZOLL Medical CorporationZOLL Medical Corporation develops medical devices and software for emergency care, with its cardiac management division best known for the LifeVest wearable cardioverter defibrillator—the world’s first wearable defibrillator. Its cardiac solutions have supported more than one million patients over more than 20 years, while helping clinicians manage acute cardiac conditions and monitor patients beyond the hospital.PITTSBURGH, PA
NuMEDFounded in a former elementary schoolhouse in Hopkinton, New York, in 1984, NuMED designs and hand-manufactures cardiovascular catheters and stents for patients with congenital heart defects, with a particular focus on pediatric care. The company pioneered its Balloon-in-Balloon technology and works closely with interventional cardiologists to develop tools for challenging procedures, now reaching patients in more than 100 countries. NuMED also provides OEM design and manufacturing services, with every device inspected throughout production and again before distribution.HOPKINTON, NY
Avery Biomedical Devices, IncFounded by Roger Avery in the late 1960s, Avery Biomedical Devices makes implanted diaphragm pacemaker systems that stimulate the phrenic nerves to support breathing. The company’s predecessor introduced the first commercially distributed diaphragm pacemaker in 1971, and Avery has since manufactured more than 10,000 neurostimulators implanted in over 50 countries. Renamed in 2005, the Long Island manufacturer’s Spirit system has full FDA approval for adult and pediatric use and is produced under an ISO 13485 quality system.COMMACK, NY